Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents

AIMS: In this pandemic, it is essential for rheumatologists and patients to know the relationship between COVID-19 and inflammatory rheumatic diseases (IRDs). We wanted to assess the role of targeted synthetic or biologic disease-modifying antirheumatic drugs (ts/bDMARDs) and other variables in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Gutierrez, Benjamin, Leon, Leticia, Madrid, Alfredo, Rodriguez-Rodriguez, Luis, Freites, Dalifer, Font, Judit, Mucientes, Arkaitz, Culebras, Esther, Colome, Jose Ignacio, Jover, Juan Angel, Abasolo, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
When Rheumatology and Infectious Disease Come Together
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869066/
https://www.ncbi.nlm.nih.gov/pubmed/33613703
http://dx.doi.org/10.1177/1759720X20962692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869066/
https://www.ncbi.nlm.nih.gov/pubmed/33613703
http://dx.doi.org/10.1177/1759720X20962692

Ejemplares similares